EVIO, Inc. (OTCMKTS: EVIO) operates as a network of ISO/IEC 17025–accredited laboratories specializing in analytical testing and research services for the cannabis, hemp, food safety and environmental markets. The company offers a comprehensive suite of assays designed to ensure product quality, safety and regulatory compliance, including potency and cannabinoid profiling, terpene analysis, pesticide screening, residual solvents detection, microbial and mycotoxin testing, heavy metals analysis and moisture content measurement. EVIO’s labs serve cultivators, processors and distributors across multiple U.S. states, such as Florida, Maryland, Maine, New Mexico and Oregon, helping clients navigate evolving state regulations and achieve consistent product standards.
Utilizing advanced instrumentation—such as high-performance liquid chromatography (HPLC), gas chromatography–mass spectrometry (GC-MS), inductively coupled plasma mass spectrometry (ICP-MS) and quantitative polymerase chain reaction (qPCR)—EVIO delivers precise, real-time results. The company’s proprietary digital data management platform enables customers to securely track and verify testing outcomes, bolstering traceability throughout the supply chain. In addition to routine compliance testing, EVIO provides specialized consulting services, method development support and on-site training to help clients enhance their quality-assurance programs and streamline approval processes.
Founded in 2014 and headquartered in Vancouver, Washington, EVIO has expanded rapidly from its origins as a single lab in Oregon to a multi-state laboratory network. The company is led by an executive team with decades of expertise in analytical chemistry, laboratory operations and regulatory affairs. The leadership group includes co-founders with backgrounds in agricultural science and food safety testing, supported by senior managers who formerly directed state-level compliance programs and academic research initiatives. This collective experience has positioned EVIO as a trusted partner for both emerging operators and established enterprises seeking to uphold rigorous safety standards.
As the regulatory landscape for cannabis, hemp and food safety continues to evolve, EVIO’s growth strategy focuses on geographic expansion, strategic partnerships and ongoing investments in research and development. The company plans to open additional laboratories in key U.S. markets, pursue select acquisitions to broaden its service offerings and introduce novel diagnostic assays that address emerging contaminants and quality markers. By staying at the forefront of testing technology and compliance best practices, EVIO aims to support the maturation of its target industries and reinforce consumer confidence in regulated products.
AI Generated. May Contain Errors.
Free EVIO Stock Alerts